Aclaris Therapeutics (ACRS) Tops Q4 EPS by 17c, Beats on Revenues

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. META
4. MU
5. SPY
6. ACN
7. NVDA
8. IBM
9. PRIM
10. PFE

Go back to Aclaris Therapeutics (ACRS) Tops Q4 EPS by 17c, Beats on Revenues
(NASDAQ: ACRS) Delayed: 4.91 +0.07 (1.45%)
Previous Close $4.84    52 Week High $33.88 
Open $4.77    52 Week Low $14.12 
Day High $5.12    P/E N/A 
Day Low $4.77    EPS $0.00 
Volume 1,131,784